Funding

Shorla Oncology raises $35m to accelerate growth

Founded in 2018 by Sharon Cunningham and Orlaith Ryan, Shorla has an advanced pipeline of innovative oncology drugs for rare, orphan and paediatric cancers

Shorla Oncology founders Orlaith Ryan and Sharon Cunningham. The company has just secured $35m in funding